Jiangsu Lianhuan Pharmaceutical Hits Day High with 10.47% Surge

Jiangsu Lianhuan Pharmaceutical Co., Ltd. has experienced a significant surge in its stock price, gaining 10.47% on March 19, 2026. The stock reached an intraday high of CNY 22.94, marking a notable performance against the backdrop of the China Shanghai Composite, which declined by 1.39% on the same day. Over the past month, Jiangsu Lianhuan has shown a robust increase of 12.51%, while its year-to-date performance stands at 23.32%. Impressively, the stock has delivered a remarkable 126.71% return over the past year, significantly outperforming the China Shanghai Composite's 16.93% gain. Despite these short-term gains, the company faces challenges, including a high debt-to-equity ratio of 1.01 and a return on equity of -2.16%. The company has reported declining profits in recent quarters, with pre-tax profit falling by 81.81% and net profit down by 83.34%. These factors contribute to a complex financial landscape for Jiangsu Lianhuan, which operates within the pharmaceuticals and biotechnology sector and holds a market capitalization of CNY 5,729 million.